Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) today provided a corporate update on its execution to expand its powerful chronic-disease screening and reporting platform, HealthTab(TM). According to the update, on Aug. 8 the company announced its entry into a new master service agreement and statement of work with Shoppers Drug Mart pharmacies. The agreement significantly expands the HealthTab point-of-care testing platform to up to 450 locations nationwide, with affiliated locations including those under the Loblaw family of brands. “The team has been exceptional in deploying systems, and we have already deployed more than half of the target locations,” said Hector Bremner, Avricore Health’s CEO. “We are on track to achieve the late-November target for full deployment.”
To view the full press release, visit https://ibn.fm/EGTKh
About Avricore Health Inc.
Avricore Health is a pharmacy service innovator focused on acquiring and developing early stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab(TM) (a wholly owned subsidiary), its mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies. For more information about the company, visit www.AvricoreHealth.com.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
